Synthorx Inc Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Synthorx, Inc. is a small biotechnology company based in La Jolla, California, focused on cancer and autoimmune diseases. It advances biologics through an expanded genetic alphabet technology that adds a new DNA base pair to extend the genetic code, enabling the creation of optimized proteins known as Synthorins. Synthorins are designed to support site-specific modifications that can enhance pharmacological properties, reflecting the company’s approach to engineering therapeutics. Its lead product candidate, THOR-707, is a variant of IL-2 under development in multiple tumor types as a standalone therapy and in combination with an immune checkpoint inhibitor. The company originated from foundational work in Dr. Floyd Romesberg’s lab at The Scripps Research Institute and is positioned within the biotechnology research industry.
1-888-653-2347 
support@leadiq.com 
